Rethinking How Histone Deacetylase Inhibitors Work
Rethinking Cancer Treatment: Why Traditional Drug Mechanisms Are Being Challenged For decades, the oncology community has operated under a relatively stable blueprint regarding how certain cancer drugs function. One of the most prominent examples involves histone deacetylase (HDAC) inhibitors—a class of drugs designed to alter how genes are turned on and off to combat tumor … Read more
